Takamasa Sakai

Statistics

Publications

Citations

191

H-Index

Active since

2013

Affiliations

Meijo University(Current)

Miyagi Prefectural Hospital Organization

Tohoku University Hospital

Tohoku University

Tohoku Medical Megabank Organization

Takamasa Sakai is an author at Meijo University specializing in clinical pharmacology, adverse drug event reporting, and adverse drug reaction reporting.

ORCID

Publications per year

2013–2022

Publications

Quality evaluation of the Japanese Adverse Drug Event Report database (JADER)

Masami Tsuchiya, Taku Obara, Takamasa Sakai et al. · Pharmacoepidemiology and Drug Safety · 2019 · 44 citations

Pharmacy, Pharmacology, Clinical Pharmacology +14

Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: a retrospective cohort study

Takahiro Kato, Takamasa Sakai, Miki Kato et al. · Thrombosis Journal · 2013 · 37 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Signal of Miscarriage with Aripiprazole: A Disproportionality Analysis of the Japanese Adverse Drug Event Report Database

Takamasa Sakai, Fumiko Ohtsu, Chiyo Mori et al. · Drug Safety · 2017 · 29 citations

Medicine, Obstetrics, Pharmacology +12

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

Takamasa Sakai, Chiyo Mori, Fumiko Ohtsu · Frontiers in Pharmacology · 2022 · 20 citations · Full text

Pharmacy, Obstetrics, Pharmacology +17

Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases

Takamasa Sakai, Chiyo Mori, Honoka Koshiba et al. · Drugs - Real World Outcomes · 2021 · 17 citations · Full text

Medicine, Obstetrics, Pharmacology +17

1–5 of 9